You are here: Industry Insights > COVID-19 Vaccine

News List

Sanofi, GSK to supply 100 mn doses of COVID-19 vaccine to US, in talks with EU for 300 mn doses expresspharma
August 03, 2020
The deal is worth $2.1 billion and involves the supply of vaccines for 50 million people, with the option to buy another 500 million doses.
Intravacc and Celonic team up to develop Covid-19 vaccine pharmaceutical-technology
July 31, 2020
Intravacc has partnered with contract development and manufacturing organisation (CDMO) Celonic Group for the design, development and production of a Covid-19 vaccine.
UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine expresspharma
July 30, 2020
The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous agreements.
Sanofi and GSK to supply Covid-19 vaccine doses to UK pharmaceutical-technology
July 30, 2020
Sanofi and GlaxoSmithKline (GSK) have signed an agreement with the UK Government to supply up to 60 million doses of a potential Covid-19 vaccine.
DCGI asks SII to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine expresspharma
July 30, 2020
SII has submitted a revised protocol for conducting the trials to the DCGI.
Sanofi/GSK sign deal with UK gov for COVID-19 vaccine pharmatimes
July 29, 2020
Sanofi and GSK have reached an agreement with the UK government for the supply of up to 60 million doses of their COVID-19 vaccine.
Emergent expands Covid-19 vaccine manufacturing deal with AstraZeneca pharmaceutical-technology
July 29, 2020
Emergent BioSolutions has entered into an agreement valued at approximately $174m for large-scale commercial production of drug substance for AstraZeneca Covid-19 vaccine candidate, AZD1222.
Pfizer-BioNTech to commence late stage study of COVID-19 vaccine candidate expresspharma
July 29, 2020
BioNTech and Pfizer informed they would begin the Phase2/3 trial to evaluate their COVID-19 vaccine candidate.
Pharma industry thinks high-risk groups should get priority for COVID-19 vaccine: GlobalData Poll expresspharma
July 29, 2020
High-risk groups include older patients, those with pre-existing conditions, at-risk ethnicities and healthcare workers.
UK government invests £100 million into COVID-19 vaccine manufacturing europeanpharmaceuticalreview
July 28, 2020
The UK government has committed £100 million to establish a centre to scale up COVID-19 vaccine and gene therapy manufacturing.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page